These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36129469)
21. Prognostic value of tumor PD-L1 expression combined with CD8 Wang Q; Lou W; Di W; Wu X Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888 [TBL] [Abstract][Full Text] [Related]
22. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients. Yip WK; Abdullah MA; Yusoff SM; Seow HF Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831 [TBL] [Abstract][Full Text] [Related]
23. [Prognostic value of T lymphocytes infiltration in breast cancer]. Yu HM; Jiao SC; Yang JL; Wang JD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010 [TBL] [Abstract][Full Text] [Related]
24. Differential gene expression of tumor-infiltrating CD8 Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653 [TBL] [Abstract][Full Text] [Related]
25. Density and location of CD3 Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989 [TBL] [Abstract][Full Text] [Related]
26. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response. Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409 [TBL] [Abstract][Full Text] [Related]
28. PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma. Jiang F; Yu W; Zeng F; Cheng G; Xu J; Yang S; Shui Y; Wu D; Yu XF; Wei Q BMC Cancer; 2019 May; 19(1):503. PubMed ID: 31138162 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. Gao G; Wang Z; Qu X; Zhang Z BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors. Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013 [TBL] [Abstract][Full Text] [Related]
31. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy. Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815 [TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128 [TBL] [Abstract][Full Text] [Related]
34. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338 [TBL] [Abstract][Full Text] [Related]
35. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711 [TBL] [Abstract][Full Text] [Related]
36. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors. de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916 [TBL] [Abstract][Full Text] [Related]
37. CD8+ T Cell Infiltration Predicts Chemoradiosensitivity in Nasopharyngeal or Oropharyngeal Cancer. Kawaguchi T; Ono T; Sato F; Kawahara A; Kakuma T; Akiba J; Sato K; Chitose SI; Umeno H Laryngoscope; 2021 Apr; 131(4):E1179-E1189. PubMed ID: 32930399 [TBL] [Abstract][Full Text] [Related]
38. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651 [TBL] [Abstract][Full Text] [Related]
39. Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment. Ono T; Azuma K; Kawahara A; Sasada T; Matsuo N; Kakuma T; Kamimura H; Maeda R; Hattori C; On K; Nagata K; Sato F; Chitose SI; Shin B; Aso T; Akiba J; Umeno H Head Neck; 2018 Sep; 40(9):2007-2019. PubMed ID: 29756253 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Hu C; Tian S; Lin L; Zhang J; Ding H Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]